Administration of neutralizing monoclonal antibody against TRAIL significantly ... IFN-γ secretion was analyzed on electronically gated NK cells, NKT cells and T cells by flow cytometry.
EBViNT, which targets Epstein–Barr virus (EBV)-positive cancers, is in phase 2 for the treatment of natural killer/T cell ... oncology antibodies. These antibodies activate T cells by binding ...